Efficacy of Postural Restriction in Treating Benign Paroxysmal Positional Vertigo

Not Applicable

• Conditions: Benign Paroxysmal Positional Vertigo

• Registration Number: NCT02475239
• Lead Sponsor: Prince of Songkla University

Brief Summary

The standard treatment of posterior semicircular canal benign paroxysmal positional vertigo is the canalith repositioning procedure or the Epley maneuver. Based on the present literature, there is controversy on the efficacy of post-maneuver postural restrictions.The aim of this study was to conduct a randomized controlled trial to compare the treatment efficacy of post-maneuver postural restriction with CRP alone in patients with posterior semicircular canal benign paroxysmal positional vertigo.

Detailed Description

Benign paroxysmal positional vertigo is the most common cause of vertigo. Based on the present literature, there is controversy on the efficacy of post-maneuver postural restrictions.Some study designs were not randomized controlled trials. The present study offers an alternative way of postural restriction to maintain postural restriction as much as possible.

Study Timeline

• Study Start: 2014-12
• Status Verified: 2015-06
• Study First Submitted: 2015-06-10
• Study First Submitted QC: 2015-06-16
• Last Update Submitted: 2015-06-16
• Study First Posted: 2015-06-18
• Last Update Posted: 2015-06-18
• Primary Completion: 2017-03
• Study Completion: 2017-06

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 186

Inclusion Criteria

• Patients with unilateral posterior semicircular canal benign paroxysmal positional vertigo and
• A negative neurologic examination

Exclusion Criteria

• Secondary benign paroxysmal positional vertigo caused by trauma head injury, inner ear surgery, viral labyrinthitis or Meniere's disease
• Patients with central vertigo, cervical spine, neurologic, otologic, psychiatric diseases
• Patients who used medications that affected the neurologic and otologic systems for less than 48 hours

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
The Dix-Hallpike test	2 weeks	The Dix-Hallpike test results

Secondary Outcome Measures

Name	Time	Method
Medication needed	24 weeks	Need of medication to treat vertigo (in this study, betahistine)
the Dizziness Handicap Inventory (DHI)	24 weeks
Resolution time	24 weeks	Time interval until the patient report recurrent vertigo confirmed by positive Dix-Hallpike
Recurrent rate	24 weeks

Trial Locations

Locations (1)

Yuvatiya Plodpoai; 🇹🇭 Hatyai, Songkhla, Thailand

Yuvatiya Plodpoai

🇹🇭Hatyai, Songkhla, Thailand

Yuvatiya Plodpoa, MD

Contact

66015988403

yuvatiya.plodpai@gmail.com